Learn how lessening the barriers for small farmers while raising them for large companies can help to steer legal cannabis markets in a more sustainable and equitable direction based on principles of community empowerment, social justice, fair(er) trade and sustainable development.

Download the report (PDF)

The coca leaf has been a staple in Andean communities for centuries, serving as a source of nutrition, as an aide for altitude adjustment, and as an energy boost. However, despite its many benefits, coca is still widely associated with its illegal derivative, cocaine. This association has led to a prohibition on the international trade of coca, holding back the coca leaf’s potential to help countries in need. Yet, the coca leaf could be at the centre of a global crop resurgence if we just take the steps needed to free it. Coca-based organic fertilisers, developed in Colombia, are an innovative, cost-effective, and environmentally friendly alternative to synthetic versions. 

An elderly cleaning lady enters the huge empty UN aula in New York with her polishing cart, to get the venue spic-and-span for an important upcoming meeting. A voice in the background explains: "Here, in this room, on the 8, 9 and 10 of June world leaders will join forces to confront the drug problem". As the lady dusts off a globe, in the swaying movement, a roaring helicopter appears spraying herbicides, followed by a fast sequence of images like burning drug crops, heavily armed soldiers and a farmer processing coffee. The voice ends with the slogan: "A drug free world - We can do it!"

From 16 to 18 October 2019, representatives of member states, intergovernmental organisations, and civil society attended the 6th Intersessional Meeting of the Commission on Narcotic Drugs. On 17 October 2019, representatives of coca and opium growers from Colombia (Pedro Arenas) and Myanmar (Sai Lone of Myanmar Opium Farmers' Forum) delivered statements highlighting the situation of communities involved in the illicit cultivation of coca and opium in both countries. Read their full statements.

The Transnational Institute (TNI) has always believed in the need to find global answers to global problems, been a strong defender of multilateralism and an advocate of a well-functioning United Nations which stands as the guarantor of universal human rights. On the drugs question, our position is straightforward: drug control should respect human rights. An accessible but comprehensive primer on why TNI believes that human rights must be at the heart of any debate on drug control.

La falta de acuerdo entre los países miembros aboca a la Comisión de Estupefacientes de la ONU (CND) a un nuevo aplazamiento de su decisión sobre la propuesta de la Organización Mundial de la Salud (OMS) de rebajar la fiscalización internacional del cannabis para facilitar su uso medicinal. La presidencia del 63 periodo de sesiones del CND ha presentado una propuesta para que sea aprobada en la mañana de este miércoles por el plenario reunido en Viena en la que insta a aplazar la votación hasta el mes de diciembre a fin de "aclarar las repercusiones y consecuencias" de las recomendaciones de la OMS. Éste es el segundo aplazamiento de la votación sobre la rebaja de la fiscalización internacional.

UN member states have agreed to hold a Ministerial Segment immediately prior to the 62^nd Session of the Commission on Narcotic Drugs (CND) ‘to take stock of the implementation of the commitments made to jointly address and counter the world drug problem, in particular in the light of the 2019 target date’ set out to eradicate or significantly reduce the overall scale of the illegal drug market. This advocacy note outlines the key issues for consideration by member states as they reflect on what has been achieved since the adoption of the 2009 Political Declaration and Plan of Action, including in light of the implementation of the UNGASS Outcome Document, and the implications for the next phase of the international drug policy regime.

Download the publication (PDF)

Two of the World Health Organization’s (WHO) cannabis scheduling recommendations might face an uphill battle getting adopted later this year by the United Nations’ Commission on Narcotic Drugs (CND). That revelation stems from an analysis of statements made by U.N.-member states at a recent two-day CND meeting. Still, many in the cannabis industry are hoping for a positive outcome at the end of the year, when a vote is planned. The reason: If the two recommendations discussed at the CND meeting in June are approved, international trade in certain CBD preparations is expected to become more free.

Recent comments by a U.S. State Department official to a United Nations (UN) drug commission are being seen by some legal experts as “a good sign” for marijuana’s potential domestic move to Schedule III under the federal Controlled Substances Act (CSA), at least in terms of clearing the country’s obligations under international law. Patt Prugh, a senior legal advisor and the primary counsel for the State Department’s Bureau of International Narcotics and Law Enforcement Affairs, told the UN’s Commission on Narcotic Drugs (CND) that the 1961 Single Convention on Narcotic Drugs and other global drug conventions take a “highly respectful” stance toward member states’ domestic policies that don’t have an “international dimension” and ought to be weighed against their duties to protect human rights.

Between 12 - 16 April 2021, the 64th session of the UN Commission on Narcotic Drugs (CND) took place in Vienna. Here you can find the statement by the Institute for Policy Studies / Transnational Institute on Inter-agency cooperation and coordination of efforts in addressing and countering the world drug problem (Agenda Item 7) about the UN System Common Position on drug policy and the establishment of the inter-agency Task Team, which provides ‘authoritative guidance’ to all UN agencies to develop and promote a truly evidence- and human rights-based drugs policy.

The World Health Organization’s (WHO) Expert Committee on Drug Dependence (ECDD or Expert Committee) released in January 2019 the outcomes of the first-ever critical review of cannabis, recommending a series of changes in the current scheduling of cannabis-related substances under the UN drug control conventions. Eagerly awaited, the ECDD recommendations contain some clearly positive points, such as acknowledging the medicinal usefulness of cannabis by removing it from Schedule IV of the 1961 Single Convention on Narcotics Drugs; clarifying that cannabidiol (CBD) is not under international control; and addressing some long-standing scheduling inconsistencies.

Download the brief (PDF)

A document prepared by the chair of the United Nations Commission on Narcotic Drugs (CND) has laid out a course to keep on track for December’s key vote on the World Health Organization’s cannabis scheduling recommendations. This is positive news for industry stakeholders concerned about a possible delay stemming from the coronavirus crisis. While the likely outcome of the vote is not yet known, it could have far-reaching implications for the global cannabis industry. One recommendation, for instance, would recognize the medical value and a lesser potential for harm of cannabis at a U.N. level – making it easier for member countries to adopt medical cannabis programs.

In November 2018, the UN System CEB adopted the ‘UN system common position supporting the implementation of the international drug control policy through effective inter-agency collaboration’, expressing the shared drug policy principles of all UN organisations and committing them to speak with one voice. The CEB is the highest-level coordination forum of the UN system, convening biannual meetings of the heads of all UN agencies, programmes and related institutions, chaired by the UN Secretary General. 

Download the briefing (PDF)

According to an email the CND Secretariat sent to permanent missions in Vienna, the “first topical meeting of the intersessional considerations of the WHO scheduling recommendations” is scheduled for June 24-25. During the gathering UN member countries are expected to discuss the implications of recommendations regarding extracts and tinctures as well as CBD. The WHO’s CBD recommendation, if ultimately adopted, could lead to freer international trade in the cannabinoid. The topical meetings, to be held behind closed doors, involve only UN-member countries and relevant intergovernmental organizations. Next week’s gathering will be the first of a series of topical meetings to be held before December.

During its reconvened 63rd session Dec. 2-4, the UN Commission on Narcotic Drugs (CND) could – with a simple majority vote in a virtual meeting based in Vienna – accept a World Health Organization (WHO) recommendation to remove cannabis and cannabis resin from Schedule IV of the 1961 Single Convention on Narcotic Drugs. Drugs in Schedule IV of the 1961 treaty – the current situation with cannabis or heroin – are a subset of those already in Schedule I, and Schedule I already requires the highest levels of international control. As such, a victory would be more symbolic than practical. (See also: Potential fall-out from the vote on the WHO cannabis recommendations)